ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,730Medicare Part D Prescriptions Filled, Including Refills

Rank: 11 out of 298

$357K Total Retail Price of All Prescriptions

Rank: 74 out of 298

329 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Dakota
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

4% of this provider’s 329 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 12,470 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

12% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$28 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
OMEPRAZOLE 684 674 1 3
POTASSIUM CHLORIDE 642 633 2 11
FUROSEMIDE 625 622 3 5
LISINOPRIL 620 600 4 4
LEVOTHYROXINE SODIUM 557 541 5 1
METOPROLOL SUCCINATE 476 476 6 12
HYDROCHLOROTHIAZIDE 403 403 7 13
PRAVASTATIN SODIUM 346 341 8 31
ATENOLOL 335 335 9 16
RANITIDINE HCL 331 331 10 59
SIMVASTATIN 329 322 11 2
LOSARTAN POTASSIUM 314 310 12 18
METOPROLOL TARTRATE 275 273 13 9
METFORMIN HCL 244 234 14 10
TRAMADOL HCL 231 227 15 15
AMLODIPINE BESYLATE 208 200 16 6
WARFARIN SODIUM 207 207 17 7
DONEPEZIL HCL 177 177 18 22
ALLOPURINOL 168 168 19 28
GLIMEPIRIDE 157 153 20 60
ATORVASTATIN CALCIUM 141 131 21 14
CARVEDILOL 141 141 21 23
CIPROFLOXACIN HCL 141 138 21 56
GEMFIBROZIL 135 131 24 65
CARBIDOPA-LEVODOPA 131 120 25 49
MELOXICAM 130 130 26 41
PAROXETINE HCL 128 124 27 48
FENOFIBRATE 125 125 28 62
TRIAMTERENE-HCTZ 116 113 29 43
GLYBURIDE 101 95 R 30 76
SERTRALINE HCL 92 92 31 19
CRESTOR 91 91 32 26
CEFADROXIL 89 79 33 202
GABAPENTIN 89 88 33 20
METOLAZONE 87 81 35 163
CITALOPRAM HBR 81 73 36 17
TERAZOSIN HCL 81 81 36 72
NABUMETONE 80 80 38 127
VERAPAMIL ER 77 77 39 88
SUCRALFATE 76 76 40 104
LANTUS 74 74 41 53
CLOPIDOGREL 72 72 42 36
ADVAIR DISKUS 71 69 43 46
NAMENDA 67 67 44 35
SYNTHROID 67 67 44 42
LACTULOSE 65 65 46 120
FENTANYL 65 65 S2 46 32
VENLAFAXINE HCL ER 63 63 48 90
ISOSORBIDE MONONITRATE ER 63 63 48 45
SPIRONOLACTONE 62 62 50 34
ZOLPIDEM TARTRATE 62 62 50 25
DIGOXIN 60 60 52 27
DILTIAZEM ER 58 58 53 116
DOXYCYCLINE HYCLATE 58 56 53 168
BUMETANIDE 58 58 53 71
ZETIA 56 56 56 83
HYDROCODONE-ACETAMINOPHEN 55 44 S3 57 8
LANOXIN 55 55 57 227
MIRTAZAPINE 54 54 59 37
HYDRALAZINE HCL 54 54 59 139
SULINDAC 52 51 61 199
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 13, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.